Clinical Trials · NCT07400107
AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,000
- Start date
- May 2026
- Locations
- 120 sites, 14 countries
- Primary endpoint
- Relative change in body weight